MedKoo Cat#: 462009 | Name: Tachysterol

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tachysterol is a normal human secosterooid metabolite from the class of vitamin D3 photoisomer derivatives. It is synthesized from 7-Dehydrocholesterol in the epidermis in response to ultraviolet irradiation.

Chemical Structure

Tachysterol
Tachysterol
CAS#115-61-7

Theoretical Analysis

MedKoo Cat#: 462009

Name: Tachysterol

CAS#: 115-61-7

Chemical Formula: C28H44O

Exact Mass: 396.3392

Molecular Weight: 396.66

Elemental Analysis: C, 84.79; H, 11.18; O, 4.03

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Tachysterol; EINECS 204-096-7; Provitamin D; Tachysterin2
IUPAC/Chemical Name
(S)-3-((E)-2-((1R,3aR,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl)vinyl)-4-methylcyclohex-3-en-1-ol
InChi Key
XQFJZHAVTPYDIQ-LETJEVNCSA-N
InChi Code
InChI=1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h8-10,12-13,19-20,22,25-27,29H,7,11,14-18H2,1-6H3/b10-9+,13-12+/t20-,22+,25-,26+,27-,28+/m0/s1
SMILES Code
CC([C@@](/C([H])=C([H])/[C@@]([C@@]1([H])CC[C@@]2([H])C(/C([H])=C([H])/C3=C(CC[C@@](O)([H])C3)C)=CCC[C@]12C)([H])C)([H])C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 396.66 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Synthesis and photochemical transformation of 3β,21-dihydroxypregna-5,7-dien-20-one to novel secosteroids that show anti-melanoma activity Michal A. Zmijewski, Wei Li, Jianjun Chen, Tae-Kang Kim, Jordan K. Zjawiony, Trevor W. Sweatman, Duane D. Miller, Andrzej T. Slominski Steroids. Author manuscript; available in PMC 2012 Jan 1.Published in final edited form as: Steroids. 2011 Jan; 76(1-2): 193–203. Published online 2010 Nov 9. doi: 10.1016/j.steroids.2010.10.009 PMCID: PMC3005096 2: Effects of sidechain length and composition on the kinetic conversion and product distribution of vitamin D analogs determined by real-time NMR Jianjun Chen, Andrzej T. Slominski, Duane D. Miller, Wei Li Dermatoendocrinol. 2013 Jan 1; 5(1): 142–149. Published online 2013 Jan 1. doi: 10.4161/derm.24339 PMCID: PMC3897582 3: Photobiology of vitamin D in mushrooms and its bioavailability in humans Raphael-John H. Keegan, Zhiren Lu, Jaimee M. Bogusz, Jennifer E. Williams, Michael F. Holick Dermatoendocrinol. 2013 Jan 1; 5(1): 165–176. Published online 2013 Jan 1. doi: 10.4161/derm.23321 PMCID: PMC3897585 4: Sunlight and Vitamin D: A global perspective for health Matthias Wacker, Michael F. Holick Dermatoendocrinol. 2013 Jan 1; 5(1): 51–108. Published online 2013 Jan 1. doi: 10.4161/derm.24494 PMCID: PMC3897598